Immunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper

BACKGROUND: The vaccines against the coronavirus disease 2019 (COVID-19) approved in the European Union represent a decisive step in the fight against the pandemic. The application of these available vaccines to patients with pre-existing immunological conditions leads to a multitude of questions re...

Descripción completa

Detalles Bibliográficos
Autores principales: Untersmayr, Eva, Förster-Waldl, Elisabeth, Bonelli, Michael, Boztug, Kaan, Brunner, Patrick M., Eiwegger, Thomas, Eller, Kathrin, Göschl, Lisa, Grabmeier-Pfistershammer, Katharina, Hötzenecker, Wolfram, Jordakieva, Galateja, Moschen, Alexander R., Pfaller, Birgit, Pickl, Winfried, Reinisch, Walter, Wiedermann, Ursula, Klimek, Ludger, Bergmann, Karl-Christian, Brehler, Randolf, Pfützner, Wolfgang, Novak, Natalija, Merk, Hans, Rabe, Uta, Schlenter, Wolfgang, Ring, Johannes, Wehrmann, Wolfgang, Mülleneisen, Norbert, Wrede, Holger, Fuchs, Thomas, Jensen-Jarolim, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Position Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212077/
https://www.ncbi.nlm.nih.gov/pubmed/34178577
http://dx.doi.org/10.1007/s40629-021-00178-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212077/
https://www.ncbi.nlm.nih.gov/pubmed/34178577
http://dx.doi.org/10.1007/s40629-021-00178-2

Ejemplares similares